Notice of Change to Key Dates for PAR-18-665 "NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)"
Notice Number:
NOT-NS-20-077

Key Dates

Release Date:

June 26, 2020

Related Announcements

PAR-18-665 - NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)

Issued by

National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAR-18-665 "NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)". This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date:April 5, 2021. Changes are shown below in bold italics.

Currently Reads:

Part 1. Overview

Key Dates:

Application Due Date(s)

April 16th thenStandard datesapply , by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review Standard datesapply
Advisory Council Review Standard datesapply
Earliest Start Date Standard datesapply
Expiration Date January 6, 2021

Modified to Read:

Part 1. Overview

Key Dates:

Application Due Date(s)

April 16th thenStandard datesapply , by 5:00 PM local time of applicant organization.

*** Note new SBIR/STTR Standard Due Dates.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review Standard datesapply
Advisory Council Review Standard datesapply
Earliest Start Date Standard datesapply
Expiration Date April 6, 2021

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Emily Caporello, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1778
Email:Emily.caporello@nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices